Michael Sapienza: Our colorectal cancer screening campaign with Phreesia has won a Gold PM360 Pharma Choice Award
Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, posted on LinkedIn:
“We’re thrilled that our colorectal cancer screening campaign with Phreesia Life Sciences has won a Gold PM360 Magazine Pharma Choice Award! The campaign, “No ifs, and, or buts – Get up to date on your Colorectal Cancer Screening,” educates patients about CRC screening and encourages them to talk to their provider about the best screening option for them.
We’re grateful for our partnership with Phreesia and the impact the point-of-care campaign has had on driving timely colorectal cancer screenings, diagnosis and intervention for patients 45 and older. Together, we’re working towards a future free of colorectal cancer.
Learn more about our winning work.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023